- Home
- ROIV vs CROX Comparison
ROIV vs CROX Comparison
Compare ROIV & CROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- CROX
- Stock Information
- Founded
- ROIV 2014
- CROX 1999
- Country
- ROIV United Kingdom
- CROX United States
- Employees
- ROIV N/A
- CROX N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- CROX Shoe Manufacturing
- Sector
- ROIV Health Care
- CROX Consumer Discretionary
- Exchange
- ROIV Nasdaq
- CROX Nasdaq
- Market Cap
- ROIV 8.4B
- CROX 8.3B
- IPO Year
- ROIV N/A
- CROX 2006
- Fundamental
- Price
- ROIV $11.83
- CROX $101.81
- Analyst Decision
- ROIV Strong Buy
- CROX Buy
- Analyst Count
- ROIV 9
- CROX 15
- Target Price
- ROIV $17.69
- CROX $150.07
- AVG Volume (30 Days)
- ROIV 4.5M
- CROX 2.1M
- Earning Date
- ROIV 11-12-2024
- CROX 10-29-2024
- Dividend Yield
- ROIV N/A
- CROX N/A
- EPS Growth
- ROIV N/A
- CROX 27.09
- EPS
- ROIV 5.89
- CROX 13.79
- Revenue
- ROIV $129,128,999.00
- CROX $4,072,432,000.00
- Revenue This Year
- ROIV $48.37
- CROX $4.94
- Revenue Next Year
- ROIV $13.76
- CROX $3.13
- P/E Ratio
- ROIV $2.01
- CROX $7.38
- Revenue Growth
- ROIV 145.68
- CROX 3.17
- 52 Week Low
- ROIV $8.61
- CROX $85.71
- 52 Week High
- ROIV $13.06
- CROX $165.32
- Technical
- Relative Strength Index (RSI)
- ROIV 51.97
- CROX 35.16
- Support Level
- ROIV $11.05
- CROX $95.05
- Resistance Level
- ROIV $12.05
- CROX $104.28
- Average True Range (ATR)
- ROIV 0.30
- CROX 3.43
- MACD
- ROIV -0.02
- CROX 0.58
- Stochastic Oscillator
- ROIV 61.86
- CROX 51.21
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include the Americas, Asia Pacific, and EMEA.